Joseph M. Zubretsky - 01 Mar 2022 Form 4 Insider Report for MOLINA HEALTHCARE, INC. (MOH)

Role
President & CEO, Director
Signature
Jeff D. Barlow, by power of attorney for Joseph M. Zubretsky
Issuer symbol
MOH
Transactions as of
01 Mar 2022
Net transactions value
+$18,430,549
Form type
4
Filing time
03 Mar 2022, 19:30:37 UTC
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MOH Common Stock Award $5,999,947 +19,238 +9.7% $311.88 216,900 01 Mar 2022 Direct F1, F2
transaction MOH Common Stock Tax liability $5,521,524 -17,704 -8.2% $311.88 199,196 01 Mar 2022 Direct F2, F3
transaction MOH Common Stock Award $35,154,490 +112,718 +57% $311.88 311,914 01 Mar 2022 Direct F2, F4
transaction MOH Common Stock Tax liability $17,202,365 -55,157 -18% $311.88 256,757 01 Mar 2022 Direct F2, F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MOH Stock Option (Right to Buy) $0 01 Mar 2022 Common Stock 375,000 $67.33 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.
F2 Represents the closing price of the Issuer's common stock on March 1, 2022.
F3 The shares were applied to the payment of withholding taxes arising in connection with the vesting of 36,484 shares on March 1, 2022.
F4 Shares issued in settlement of performance stock units granted in 2019 which vested at the 200% max level based on the achievement of cumulative net income metric over the three fiscal years of 2019, 2020 and 2021.
F5 Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.
F6 The shares shall vest as follows: the 19,238 newly granted shares vest in one-third increments on each of March 1, 2023, March 1, 2024, and March 1, 2025. Additional shares shall vest as follows: 23,959 shares on March 1, 2023 and 8,999 on March 1, 2024. The remaining shares are vested.
F7 The options are fully vested.